Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
about
Targeting serous epithelial ovarian cancer with designer zinc finger transcription factorsMetastasis suppressor genesNovel CD9-targeted therapies in gastric cancerCD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinaseKAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy.Down-regulation of CD9 expression and its correlation to tumor progression in B lymphomas.Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model.Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancerTetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma.The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organizationDown-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma.Intravenous KITENIN shRNA injection suppresses hepatic metastasis and recurrence of colon cancer in an orthotopic mouse model.KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.Role of tumor cell adhesion and migration in organ-specific metastasis formation.Effects of KAI1 gene on growth and invasion of human hepatocellular carcinoma MHCC97-H cells.Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model.Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression arrayThe tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation.KAI1 gene is differently expressed in papillary and pancreatic cancer: influence on metastasis.Clinical significance of transmembrane 4 superfamily in colon cancer.Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck.Functional implications of tetraspanin proteins in cancer biology.CD9 Expression in Colorectal Carcinomas and Its Prognostic SignificanceMyoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.Tetraspanins in human epithelial malignancies.Metastasis-suppressor genes in clinical practice: lost in translation?Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer.Co-localization of beta1,6-branched oligosaccharides and coarse melanin in macrophage-melanoma fusion hybrids and human melanoma cells in vitro.Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity.MRP1 and its role in anticancer drug resistance.Therapeutic antibodies against cancer stem cells: a promising approach.Upregulation of CD9 in ovarian cancer is related to the induction of TNF-α gene expression and constitutive NF-κB activation.Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression.Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach.
P2860
Q24605597-DBD6DF2B-2059-429B-9051-A64C239C9467Q26866948-B9C1B352-4916-45F5-A240-06832B7CA2B2Q27026877-E4820557-2985-4B3C-85AE-32F3268F7F66Q28214450-778C0CF6-EBBA-4ED4-B305-F731CC5B839DQ30444871-34DA3BFF-0963-4184-8500-41F27CA815BAQ30891820-41C54C73-35E4-4336-905E-9ABF95838200Q33613734-57143496-8A7F-4BFE-B16E-F78D4963B585Q33805534-191E8ACA-8832-4B5C-BE78-56AA472B4F56Q33947304-7AA589C7-A7A5-4220-AD6F-30A0B987E226Q34211752-E3272C85-F3C5-4008-9ACE-448F09461427Q34452282-0023C7BF-7BCD-4068-BDED-9A19228AA5EDQ34781970-0D6FC744-E71A-4CD2-A08C-23FC2E72A967Q34914039-91AAAB0E-F58E-4056-8998-0A81246596D9Q35023643-E1C5CA02-85D2-43EA-AC98-39568C6EE090Q35140877-99F815EE-9509-4E48-B671-CD86B6C55BE9Q35161600-0C108603-686F-4CCE-990F-3D8BF2111428Q35511498-3FAD5741-ACD6-4884-ADA5-25D55CCEEE69Q35550219-73C92AB9-EEC6-4994-A233-388AB6CD8416Q35787114-435D3E2F-1666-48D3-B4A5-4EBF70AF9F82Q35980557-936DC800-3D14-4AF1-981F-0EDFBD68BB82Q36066180-2AA2DAD1-6D4C-4038-BF17-AD0EA71C0B82Q36109993-67F515CF-F9CE-4D57-BAE4-A7A1854E4994Q36308160-99EFBEE4-F8C2-4540-92E6-25523F4880ACQ36327499-CE01C789-9164-43DA-8ACE-934F666811FBQ36506438-242403BA-2818-4889-A3DC-48E354E41BD4Q36670743-3998FEB0-FD7B-467C-979B-D526DC5B2636Q36694353-3CE674A9-4A60-464C-8420-1102AF935268Q36922587-E3A92313-7D53-4CB2-A2E5-708F48957D6DQ37438721-BD27793F-6A21-4392-A575-A88F915127E5Q37696362-E4005444-BF37-4468-A35C-9C5C5080079CQ37799578-DF3F52D8-21B6-4913-BD89-50DDA2185703Q37869335-C0550684-205F-460D-85C3-1A05F3019791Q38416282-EE6CD88B-8665-4332-8DD4-67347BE03B42Q38447801-1BAA0BBF-19E6-4632-9E10-6C85DDB0F133Q38579796-060985B7-19C4-4548-856E-3CCDB50227D3Q38626237-115C61A5-1D93-4B5A-A7A7-381A473D8A19Q38637435-07CF0CFB-FA67-40E0-8D2A-E68F44B5E38CQ39441192-D81456C6-10AE-493E-B6FE-632CDF318BF6Q39574037-D9E570BD-3184-4ABE-A30C-C1B3D06F5A90Q39672356-056F1861-B3EC-49A2-97C1-5C9294D0303A
P2860
Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Correlation of reduction in MR ...... ces in breast cancer patients.
@ast
Correlation of reduction in MR ...... ces in breast cancer patients.
@en
type
label
Correlation of reduction in MR ...... ces in breast cancer patients.
@ast
Correlation of reduction in MR ...... ces in breast cancer patients.
@en
prefLabel
Correlation of reduction in MR ...... ces in breast cancer patients.
@ast
Correlation of reduction in MR ...... ces in breast cancer patients.
@en
P2093
P2860
P1476
Correlation of reduction in MR ...... ces in breast cancer patients.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65639-8
P407
P577
1998-09-01T00:00:00Z